Studies demonstrate that increased melanin density helps absorb harmful UV radiation and reduce oxidative DNA damage in skin cells
Due to the absence of regulatory oversight for research-only compounds, parameters such as purity, potency, and sterility can vary significantly across different laboratory suppliers
The comparison breaks down like this
For a 200-pound person, this translates to 24 to 30 pounds with semaglutide and 30 to 38 pounds with tirzepatide
From the perspective of a molecular cardiovascular postdoctoral researcher with a background in genetic engineering, the availability of an oral semaglutide is a meaningful step toward improving patient adherence and broadening access to cardiometabolic therapies
The FDA has escalated enforcement against compounded GLP-1 marketing since September 2025, Novo Nordisk launched the first FDA-approved oral semaglutide pill in January 2026, and compounding pharmacy supply chains are narrowing as regulatory pressure increases